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Yeast U5 small nuclear ribonucleoprotein particle (snRNP) is assembled via a cytoplasmic precursor that contains the
U5-specific Prp8 protein but lacks the U5-specific Brr2 helicase. Instead, pre-U5 snRNP includes the Aar2 protein not
found in mature U5 snRNP or spliceosomes. Aar2p and Brr2p bind competitively to a C-terminal region of Prp8p that
comprises consecutive RNase H-like and Jab1/MPN-like domains. To elucidate the molecular basis for this
competition, we determined the crystal structure of Aar2p in complex with the Prp8p RNase H and Jab1/MPN
domains. Aar2p binds on one side of the RNase H domain and extends its C terminus to the other side, where the
Jab1/MPN domain is docked onto a composite Aar2p–RNase H platform. Known Brr2p interaction sites of the Jab1/
MPN domain remain available, suggesting that Aar2p-mediated compaction of the Prp8p domains sterically interferes
with Brr2p binding. Moreover, Aar2p occupies known RNA-binding sites of the RNase H domain, and Aar2p interferes
with binding of U4/U6 di-snRNA to the Prp8p C-terminal region. Structural and functional analyses of phospho-
mimetic mutations reveal how phosphorylation reduces affinity of Aar2p for Prp8p and allows Brr2p and U4/U6
binding. Our results show how Aar2p regulates both protein and RNA binding to Prp8p during U5 snRNP assembly.
[Keywords: assembly chaperone; pre-mRNA splicing; regulation by phosphorylation; snRNP biogenesis and recycling;
X-ray crystallography]
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Uridine-rich (U) small nuclear ribonucleoprotein parti-
cles (snRNPs) are the main subunits of spliceosomes, the
large and dynamic RNP machineries required for the
removal of noncoding introns from eukaryotic precursor
messenger RNAs (pre-mRNAs) and the ligation of neigh-
boring coding exons. The major spliceosome is built from
the U1, U2, U4, U5, and U6 snRNPs, each of which con-
tains an individual small nuclear RNA (snRNA), seven
common Sm proteins (or like-Sm [LSm] proteins in the
case of U6), and a variable set of particle-specific proteins
(for review, see Will and Lu¨hrmann 2001).
A hallmark of the spliceosome is its stepwise assembly
from snRNPs and many non-snRNP factors only in the
presence of a substrate pre-mRNA (for review, see Wahl
et al. 2009). During this process, the spliceosome is re-
peatedly remodeled with the help of eight highly con-
served DEXD/H-box ATPases/RNA helicases (for review,
see Staley and Guthrie 1998). Among these enzymes, the
U5-specific Brr2 protein is required for the catalytic
activation of an initial inactive spliceosomal assembly
and again during the ordered disassembly of the post-
splicing complex (for review, see Hahn and Beggs 2010).
Brr2p is regulated by two other U5 snRNP proteins:
Prp8p, considered the master regulator of the spliceosome
(for review, see Grainger and Beggs 2005), and Snu114p,
a complex G protein that resembles the ribosomal trans-
locase eEF2 (Bartels et al. 2002, 2003; Brenner and Guthrie
2005; Small et al. 2006).
The Sm-type snRNPs themselves are also assembled in
a strictly controlled fashion in vivo (for review, see Patel
and Bellini 2008). Their snRNAs are generated by RNA
polymerase II, receive a 7-methyl-guanylate cap, and are
exported to the cytoplasm. Here, the Sm proteins are at-
tached in a ring-like fashion around a uridine-rich Sm site
of the snRNAs (Pomeranz Krummel et al. 2009; Weber
et al. 2010; Leung et al. 2011). This process is mediated by
two coordinated multifactorial assembly machineries:
the protein arginine methyltransferase 5 (PRMT5) com-
plex and the survival of motor neurons (SMN) complex
(for reviews, see Battle et al. 2006; Fischer et al. 2011).
After assembly of the Sm core RNPs, the snRNA caps are
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turned to the nucleus. Final stages of snRNP assembly
take place in the nuclear Cajal bodies, where the particle-
specific proteins are thought to be added (Nesic et al.
2004; Schaffert et al. 2004; Stanek and Neugebauer 2004).
Furthermore, U4, U5, and U6 snRNPs assemble a U4/U6-
U5 tri-snRNP in the Cajal bodies (Schaffert et al. 2004)
before incorporation into spliceosomes.
In yeast, a cytoplasmic precursor of U5 snRNP—con-
taining only the U5 snRNA, the Sm proteins, and the U5-
specific proteins Prp8p and Snu114p—has been charac-
terized (Gottschalk et al. 2001; Boon et al. 2007). Pre-U5
snRNP lacks the Brr2 helicase and instead includes the
Aar2 protein (Gottschalk et al. 2001; Boon et al. 2007),
which has been originally characterized as a factor in-
volved in pre-mRNA splicing of the MATa1 transcript in
Saccharomyces cerevisiae (Nakazawa et al. 1991). We
recently found that Aar2p and Brr2p bind, respectively, to
an RNase H-like (RH) domain and a Jab1/MPN-like (Jab1)
domain that lie next to each other in the C-terminal
region of the Prp8 protein (Weber et al. 2011). Moreover,
binding of Aar2p to the Prp8p RH domain sequestered the
Jab1 domain and counteracted Brr2p binding to Prp8p
(Weber et al. 2011). Furthermore, Aar2p was shown to be
phosphorylated at five sites in vivo, and a phospho-
mimetic mutation of Aar2p (S253E) diminished binding
to the RH domain in vitro and abolished Aar2p–Prp8p
interaction in extracts, allowing increased association of
Brr2p with Prp8p (Weber et al. 2011).
To further elucidate the molecular basis for the func-
tion of Aar2p as a U5 snRNP assembly factor, we deter-
mined the crystal structure of Aar2p in complex with the
Prp8p RH and Jab1 domains. In the complex, Aar2p pack-
ages the two Prp8p domains in a manner incompatible
with Brr2p binding. In addition, we show that Aar2p in-
terferes with the binding of U4/U6 di-snRNAs to the
Prp8p C-terminal region and demonstrate how reversible
phosphorylation can regulate these activities.
Results
Reconstitution and structure analysis of an
Aar2pDloop–RH–Jab1 complex
Our previous crystal structure of subtilisin-treated Aar2p
(Aar2pSubt) in complex with the Prp8p RH domain did not
reveal how this complex sequesters the Jab1 domain
(Weber et al. 2011). We could not use Aar2pSubt to as-
semble a complex with both Prp8p domains, as this protein
lacks a C-terminal expansion that is required for Jab1 se-
questration (Weber et al. 2011). We thus generated com-
plexes via two alternative strategies. First, we coproduced
and copurified Aar2p with a Prp8p C-terminal fragment
(CTF) encompassing both RH and Jab1 domains. Second,
we coproduced and copurified Aar2p with the Prp8p RH
domain, added a separately purified Jab1 domain, and
purified the resulting complex by gel filtration chroma-
tography. In both strategies, we used either wild-type
Aar2p or a variant in which a flexible internal loop
(residues 153–170) was replaced by five serine residues
(Aar2pDloop) (Supplemental Fig. S1). The same loop was
also removed by the subtilisin treatment in Aar2pSubt
(Weber et al. 2011).
All attempts to crystallize CTF together with wild-type
Aar2p or Aar2pDloop failed, most likely due to an ;60-
residue flexible linker between the RH and Jab1 domains.
In addition, we did not obtain crystals from trials involving
wild-type Aar2p and the two separate Prp8p domains.
However, the Aar2pDloop–RH–Jab1 complex (i.e., a ‘‘ter-
nary’’ complex in which the RH and Jab1 domains were
separated by removal of the intervening linker) (Supple-
mental Fig. S2A, lanes 2,3) yielded crystals (Supplemental
Fig. S2B) that diffracted to 2.1 A˚ resolution (Supplemental
Table S1). The structure was solved by molecular re-
placement using the structure coordinates of Aar2pSubt
and RH (Protein Data Bank [PBD] ID 3SBT) and refined to
low R/Rfree factors with good stereochemistry (Supple-
mental Table S1).
Overall structure of an Aar2pDloop–RH–Jab1 complex
In the structure of the Aar2pDloop–RH–Jab1 complex, the
three molecules form a linear array with the RH domain
in the center and the bulk of the other two proteins on
either side (Fig. 1A,B). We previously described the struc-
ture of the RH domain as a left-handed mitten with the
RH-like portion representing the ‘‘palm,’’ an extended b
hairpin corresponding to the ‘‘thumb,’’ and an a-helical
subdomain forming the ‘‘fingers’’ (Pena et al. 2008). Aar2p
is divided into an N-terminal domain with a b-sandwich
fold and an a-helical C-terminal domain (Fig. 1A). The
Aar2p C-terminal domain interacts with one side of the
RH palm, burying 448 A˚2 of surface area (Fig. 1C, panel
I). This interface includes a number of hydrophobic
contacts (residues M195, F198, and L199 in helix a6 of
Aar2p interacting with W1911 of RH; residues F198 and
L189 of Aar2p contacting V1946 of RH), a salt bridge
(Aar2p R186 with RH D1950), and water-mediated
interactions (between Aar2p R186 and RH V1946 and
D1950).
The Jab1 domain is located remote from this Aar2p–RH
interface on the other side of the RH domain (Fig. 1B). The
Aar2p C terminus is preceded by a flexible unstructured
peptide (residues 318–338) and extends across the RH palm,
where it acts in concert with RH to generate a composite
surface to which the Jab1 domain is attached. The C
terminus of Aar2p connects the two Prp8p domains via
a parallel, intermolecular b sheet, interspersing between
one b strand of the RH thumb and the central b barrel of
Jab1 (Fig. 1B). The composite binding site for the Jab1
domain is consistent with previous interaction studies,
in which neither Aar2p nor RH alone formed stable
complexes with Jab1 (Weber et al. 2011). The described
Aar2pDloop–RH–Jab1 complex is the only arrangement in
the present crystal structure in which the connecting
peptide lacking electron density (21 residues) can easily
bridge between the globular part of Aar2pDloop and the
C-terminal extension (21 A˚ distance compared with
49 A˚ for the next closest possibility).
Apart from the secondary structure-based backbone
hydrogen bonds, the side chains in the C-terminal b strand
Weber et al.
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of Aar2p maintain intricate interactions with both Prp8p
domains (Fig. 1C). The interaction between the Aar2p C
terminus and the RH palm and thumb regions (733 A˚2 of
buried surface area) (Fig. 1C, panels II,III) involves amixture
of hydrophobic contacts (Aar2p P344 with RH Y1858 and
V1860; Aar2p T345 with RH T1855; Aar2p I346 and V347
with RH V1860, V1862, and I1875; and Aar2p Y351 with
RH V1862), a hydrogen bond (Aar2p P344 and RH S1906),
a cation–p interaction (Aar2p R354 with RH F1866),
and water-mediated interactions (between Aar2p T345
and RH R1937 and T1855). The interface between the
C-terminal b strand of Aar2p and Jab1 (508 A˚2) (Fig. 1C,
panel IV) is dominated by hydrophobic interactions (Aar2p
Y351 with Jab1 Y2170 and RH V1862; Aar2p L350 with
Jab1 I2169, V2171, and L2341; and Aar2p Y352 with Jab1
V2171 and L2340) with an interspersed hydrophilic
contact (Aar2p Y352 with the backbone of Jab1 L2341).
The two very C-terminal residues of Aar2p are deeply
Figure 1. Structure of the Aar2pDloop–RH–Jab1
complex. (A) Scheme showing domains and features
of Aar2p and Prp8p constructs used in this study.
(NTD) Aar2p N-terminal domain; (CTD) Aar2p
C-terminal domain; (CE) Aar2p C-terminal exten-
sion. (B) Ribbon plot of the Aar2pDloop–RH–Jab1
complex. (Red) Aar2pDloop; (blue) RH; (cyan) Jab1;
(dashed red line) flexible Aar2p peptide preceding
the C terminus; (internal loop) flexible loop of Aar2p
connecting its two domains, which in Aar2pDloop
was replaced by five serines. The N and C termini as
well as the RH palm, thumb, and finger regions are
labeled. Roman numerals indicate the location of
the protein–protein interface regions depicted in C,
panels I–VI. (C) Close-up views on protein–protein
interface regions of the Aar2pDloop–RH–Jab1 struc-
ture. Interacting residues are shown as sticks and
colored by atom type. The color of the carbon is the
same as the molecule to which it belongs. Nitrogen
is in blue, oxygen is in red, and sulfur is in yellow.
Water molecules are shown as green spheres. Dashed
lines represent hydrogen bonds or salt bridges. Rota-
tion symbols indicate the views relative to B. (D,E)
ITC experiments comparing the binding of wild-type
Aar2p (D) and a C-terminal Aar2p extension (residues
331–355) (E) to CTF. Thermodynamic binding pa-
rameters are listed. Icons indicate Aar2p variants
(red) and CTF variants (RH [blue]; Jab1 [cyan]) used.
Dual function of Aar2p in snRNP assembly
GENES & DEVELOPMENT 527
involved in the interaction network, providing a crucial
anchor for RH and Jab1 (Fig. 1C, panel V). The pen-
ultimate R354 is positioned by Jab1 residues D2174
and D2175 for stacking on F1866 of RH, while the
C-terminal carboxyl group of P355 engages in additional
salt bridges with K2267 of Jab1. The interface of RH and
Jab1 (481 A˚2) (Fig. 1C, panel VI) is formed by a short
interdomain a-helical bundle (RH M2024 and E2020
intercalated between Jab1 I2157, L2161, and L2164).
As the C-terminal expansion of Aar2p covers 1195 A˚2
of surface area with RH and Jab1, we tested whether it
alone binds efficiently to CTF. Isothermal titration calo-
rimetry (ITC) experiments showed that the dissociation
constant of a C-terminal Aar2p peptide (residues 331–
355) and CTF was >1500 times larger compared with
wild-type Aar2p due to a concomitant decrease in reaction
enthalpy and increase in reaction entropy (Fig. 1D,E).
Therefore, the interaction of the RH domain with the
globular part of Aar2p provides a crucial initial anchor for
the Aar2p C-terminal expansion to efficiently connect RH
and Jab1.
Reassignment of the physiological Aar2p–RH interface
The interface between Aar2p and RH in the present
complex differs markedly from the interaction reported
for the Aar2pSubt–RH complex (Weber et al. 2011), where
Aar2pSubt was described to bind between the thumb and
fingers of RH (Supplemental Fig. S3A). The previous
assignment of the Aar2pSubt–RH interface was based on
a large buried surface area (755 A˚2 compared with 440 A˚2
for the next largest contact in the crystal lattice) involv-
ing 54 contacting residues and a high degree of charge
complementarity between themolecules. Crystal contacts
with buried surface areas >600 A˚2 have a high likelihood
of being physiologically relevant (Janin 1997; Krissinel
2009). In addition, Prp8pmutations with enhanced affinity
to Brr2p (van Nues and Beggs 2001) and an Aar2p muta-
tion (D281N) that suppressed a slowdown of spliceo-
some catalytic activation caused by the prp38-1 allele
(Pandit et al. 2006) mapped to the presumed Aar2pSubt–RH
interface and could be explained by a reduced binding of
Aar2p to the Prp8p RH domain. While the present struc-
ture still rationalizes the enhanced Brr2 affinity of certain
Prp8p mutations (see the Discussion), Aar2p residue D281
is not involved in contacts to RH or Jab1 in our new struc-
ture, which therefore does not explain the genetic effects
of the D281N mutation.
While there is also no other crystal contact in the
present structure that resembles the previously assigned
Aar2pSubt–RH complex, an alternative interaction be-
tween Aar2pSubt and RH exists in the Aar2pSubt–RH
crystal lattice, which closely resembles the interaction
observed in the Aar2pDloop–RH–Jab1 complex (overall
root-mean-square deviation [rmsd], 4.16 A˚; rmsd Aar2p
components, 1.37 A˚; rmsd RH components, 1.62 A˚)
(Supplemental Fig. S3B,C). While the molecular con-
tacts in the two complexes are almost identical (Sup-
plemental Fig. S3B,C), the small size of the interface
(;450 A˚2) still allows for small deviations in the rel-
ative positioning of the two proteins (Supplemental Fig.
S3E).
To sort out the physiological Aar2p–RH interaction
mode, we mutated residues in either interface and ob-
served their effects on comigration of Aar2p and RH in
gel filtration (Fig. 2; Supplemental Fig. S4). Double muta-
tions R55A/I282A in Aar2p (Supplemental Fig. S4D) or
V1862A/N2062A in RH (Supplemental Fig. S4E), which
introduced changes in residues involved in the previously
suggested Aar2pSubt–RH interface, as well as the combi-
nation of both double mutants (Supplemental Fig. S4F)
still permitted the formation of dimeric Aar2p–RH com-
plexes. Conversely, mutation of residues in the Aar2p–
RH interface seen in the present complex had clear
effects on complex formation (Fig. 2). Whereas the single
residue changes M195A or R186A in Aar2p did not
disrupt the complex with RH (Fig. 2D,E), the interac-
tion was abolished with the combined double Aar2p
mutation (Fig. 2F). Likewise, the V1946A mutant of
RH still bound to Aar2p (Fig. 2G), but the interaction
was abolished when we combined this mutation with
Aar2pM195A (Fig. 2H). Finally, changing W1911 of RH,
which maintains extensive hydrophobic interactions
with Aar2p (Fig. 1C, panel I), to alanine also interfered
with Aar2p binding (Fig. 2I).
All proteins used in this study showed cooperative
transitions in a fluorescence-based thermal melting assay
(Supplemental Table S2), indicating that introduced mu-
tations did not compromise their overall folds. Further-
more, the observation that several individual and double
mutations in Aar2p (M195A, R186A, and R55A/I282A) or
RH (V1946A and V1862A/N2062A) still supported com-
plex formation demonstrates that these amino acid ex-
changes left the overall structures of Aar2p and RH intact.
We also crystallized the RHW1911A protein alone and found
its structure to be virtually unchanged compared with the
wild-type protein (rmsd, 0.55 A˚ and 1.19 A˚ for two in-
dependent molecules per asymmetric unit) (Supplemental
Table S1).We also ascertained that theAar2p internal loop,
which was replaced by five serines in Aar2pDloop or cleaved
in Aar2pSubt, is not involved in the interaction with RH or
Jab1 (SupplementalMaterial; Supplemental Fig. 5). Finally,
while this study was being revised, a structure of Aar2p in
complex with a larger portion of Prp8p (residue 885-2413)
was published (Galej et al. 2013). The corresponding parts
of this and our Aar2pDloop–RH–Jab1 structure are very
similar (overall rmsd, 2.64 A˚; rmsd Aar2p components,
2.12 A˚; rmsd RH components, 1.18 A˚; rmsd Jab1 compo-
nents, 1.34 A˚). Taken together, the above analyses clearly
show that the contact between Aar2p and RH seen in the
present structure represents their physiological interac-
tion mode.
The Aar2pDloop–RH–Jab1 structure resolves ambiguities
in the domain arrangement of a CTF structure
Although CTF did not cocrystallize with Aar2p in our
hands, we had previously been able to determine the
crystal structure of CTF alone (Weber et al. 2011) but,
due to missing electron density for the flexible RH–Jab1
Weber et al.
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Figure 2. Alanine-scanning mutagenesis probing the Aar2p–RH interaction. (A–I) Gel filtration analyses assessing the interaction
between Aar2p and RH and mutant variants. A–C are identical to Supplemental Figure S4, A–C. All mutated residues contribute to
interface I (Fig. 1C). (Left) SDS-PAGE analysis of the eluted gel filtration fractions (indicated at the top of A). The first two lanes show
the protein standard (M) and the gel filtration input (I). Molecular mass of the standard proteins in kilodaltons are shown on the left, and
protein names are on the right. (Middle) Elution profiles of the respective gel filtration runs. Fractions corresponding to the SDS-PAGE
analysis are highlighted in gray, fraction numbers are shown at the top of A, and elution volumes are at the bottom of I. Dashed lines
across the elution profiles indicate the elution peaks of molecular mass standards (molecular masses are given at the bottom). Icons
denote single proteins or complexes and are defined above the middle panels. Stars denote point mutations. Transparent icons
represent an excess of the respective protein running separate from the complex. (Right) Close-up views on the mutated residues
(underlined) and their interactions across the Aar2p–RH interface.
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linker, could not reliably assign a physiological contact
between the RH and Jab1 domains. We observed that one
interactionmode of the two domains in the isolated CTF
structure closely corresponds to the RH–Jab1 interaction
in the Aar2pDloop–RH–Jab1 complex (Supplemental Fig.
S3D,F). In the CTF structure, the thumb of RH has a
different conformation and sustains additional contacts
to Jab1 (RH V1862 and V1870 to Jab1 residues 2343–
2346). In the Aar2pDloop–RH–Jab1 complex, the C terminus
of Aar2p interjects between these regions, bridging be-
tweenRH and Jab1 (Fig. 1B). Thus, rather than sequentially
interacting first with RH and subsequently with Jab1,
Aar2p may bind to a preformed complex between the
domains and subsequently stabilize their interaction via
its C terminus.
The composite Aar2p–RH surface is required
for the sequestration of Jab1
We next tested the physiological relevance of the Aar2p–
Jab1 and RH–Jab1 contacts seen in the Aar2pDloop–RH–
Jab1 complex by mutating residues in the respective
interfaces. As Jab1 does not stably interact with Aar2p
or RH alone and as we could not monitor whether Jab1
was stably sequestered in mutant Aar2p–CTF complexes,
we investigated the effects of mutations on binding of
Jab1 to preformed Aar2p-–RH complexes by size exclusion
chromatography (Fig. 3). Alanine substitution of L350 or
Y352 (Fig. 1C, panel IV) at the very C terminus of Aar2p
interfered with binding of Jab1 to the mutant Aar2p–RH
complexes (Fig. 3D,E). Likewise, the reciprocal Y2170A
Figure 3. Alanine-scanning mutagenesis probing the Aar2p–Jab1 and RH–Jab1 interfaces. (A–G) Gel filtration analyses assessing the
interaction between the Aar2p–RH complex and Jab1 and variants. A is identical to Figure 2C. Roman numerals in the panels on the
right identify the respective interface (Fig. 1C). Other details and labels are as in Figure 2. Icons representing the proteins are defined in
the top right. Rotation symbols indicate the views relative to Figure 1B.
Weber et al.
530 GENES & DEVELOPMENT
mutation in Jab1 (Fig. 1C, panel IV) failed to form a com-
plex with Aar2p–RH (Fig. 3F). The same result was ob-
tained with a L2161A variant of Jab1 (Fig. 3G) in which
a residue in the center of the RH–Jab1 interface is affected
(Fig. 1C, panel VI). These results show that the integrity of
both the Aar2p–Jab1 and the RH–Jab1 interfaces is re-
quired for efficient binding of Jab1 to Aar2p–RH.
Brr2p interacts with CTF in gel filtration (Fig. 4A), but
addition of Aar2p leads to formation of an Aar2p–CTF
complex that excludes Brr2p (Weber et al. 2011). To in-
vestigate whether stable binding of the Jab1 domain to
the composite Aar2p–RH binding site is required for ex-
clusion of Brr2p from CTF, we introduced the above
mutations into Aar2p or CTF and investigated the effect
on Brr2p binding. We predicted that the mutations would
lead to detachment of Jab1 from the Aar2p–RH subcom-
plex and allow formation of a complex in which Aar2p
is bound to RH and Brr2p is bound to Jab1. In line with
the observation that Aar2pL350A–RH fails to bind Jab1
(Fig. 3D), the Aar2pL350A mutant allowed formation of
an Aar2pL350A–CTF–Brr2p complex (Fig. 4C). Similarly,
CTFY2170A bearing a mutation in its Jab1 portion that
interfered with Aar2p–RH–Jab1 complex formation (Fig.
3F) allowed concomitant binding of Aar2p and Brr2p to
CTF (Fig. 4D). Finally, the same result was obtained with
the CTFL2161A variant (Fig. 4E), which carries a mutation
Figure 4. Effect of Aar2p and CTF variants on Brr2p binding. (A–F) Gel filtration analyses probing the interaction between Aar2p and
CTF variants and Brr2p. Roman numerals in the panels on the right identify the respective interface (Fig. 1C). Other details and labeling
are as in Figure 2. Icons representing the proteins are defined in the top right. (A) Brr2p binds the CTF. Rotation symbols indicate the
views relative to Figure 1B. (B) Aar2p sequesters CTF from Brr2p. (C,D) Mutations affecting the interaction of the Aar2p C terminus
with Jab1 allow the formation of a Aar2p–CTF–Brr2p complex. (E) Same effect of a mutation in the interface between RH and Jab1. (F) A
double mutation in the Aar2p–RH interface does not allow Aar2p binding to the Brr2p–CTF complex.
Dual function of Aar2p in snRNP assembly
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in the RH–Jab1 interface detrimental to Aar2p–RH–Jab1
complex formation (Fig. 3G).
In contrast to the mutations that affect the Aar2p–Jab1
or RH–Jab1 interfaces, the Aar2pR186A/M195A double mu-
tant, which fails to form a complex with RH (Fig. 2F), was
not able to sequester CTF from Brr2p or enter a Brr2p–CTF
complex (Fig. 4F). Together, these results indicate that
a stable interaction between the globular part of Aar2p and
the palm of the Prp8p RH domain is a prerequisite for
Aar2p to extend its C terminus across the RH domain and
form a composite interface for Jab1 binding. Binding of
Jab1 to this composite interface effectively counteracts
Brr2p binding to the Jab1 domain.
A covalent connection between RH and Jab1 domains
is required for Aar2p-mediated exclusion of Brr2p
While Aar2p was able to bind CTF in a manner that ex-
cluded Brr2p (Fig. 4B), Brr2p titrated the isolated Jab1
domain from an Aar2p–RH–Jab1 complex (Supplemental
Fig. S6A); i.e., when the RH and Jab1 domains were not
connected by the ;60-residue intervening linker. We
therefore investigated whether the linker itself estab-
lishes additional contacts that stabilize the Aar2p–CTF
complex. To this end, we produced and purified a Jab1
construct that contained the entire linker sequence
(Jab1linker; an analogous RHlinker construct was not pro-
duced soluble in Escherichia coli). The presence of the
linker on Jab1 still allowed Brr2p to titrate the Jab1linker
portion from an Aar2p–RH complex (Supplemental Fig.
S6B). To investigate the binding thermodynamics of Jab1
and Jab1linker to Aar2p–RH, we conducted ITC experi-
ments. Both Jab1 and Jab1linker bound to Aar2p–RH stoi-
chiometrically (Supplemental Fig. S6C,D). The affinity of
Jab1linker to Aar2p–RH was slightly reduced compared
with Jab1 due to a larger entropy loss upon binding (Sup-
plemental Fig. S6C,D). Together, these results suggest that
the RH–Jab1 linker does not reinforce the Aar2p–CTF in-
teraction by fostering direct contacts. Instead, it acts by
tethering the two Prp8p C-terminal domains and thus
increasing the local concentration of Jab1 in the neigh-
borhood of RH and Aar2p.
Aar2p blocks U4/U6 di-snRNA binding to CTF
The Prp8p RH domain has been suggested to provide a
platform for RNA transactions during spliceosome cata-
lytic activation (Pena et al. 2008). Furthermore, it has
been shown to bind several RNAs in vitro (Ritchie et al.
2008; Yang et al. 2008), with U4/U6 di-snRNA represent-
ing the strongest interactor known to date (Zhang et al.
2009; Mozaffari-Jovin et al. 2012). Notably, in our present
Aar2pDloop–RH–Jab1 structure, the C terminus of Aar2p
occupies several regions on the RH domain that have
been implicated in contacting RNA by cross-linking and
genetic interactions (Fig. 5A). In particular, the Aar2p C
terminus contacts the palm next to an area that could
be cross-linked to the 59 splice site at an early step of
spliceosome assembly (Reyes et al. 1996, 1999). It directly
interacts with residues V1860, T1861, V1862, and I1875
at the base of the thumb (Fig. 1C, panels II,III). Some prp8-
cat alleles (Grainger and Beggs 2005) lead to mutations in
these Prp8p residues and suppress u4-cs1 phenotypes
originating from a hyperstabilized U4-cs1/U6 duplex
(Kuhn et al. 1999; Kuhn and Brow 2000). Aar2p also in-
teracts at the tip of the thumb, where mutations sup-
press defects in either splice site or the branch point se-
quence of a pre-mRNA (Umen and Guthrie 1995, 1996;
Collins and Guthrie 1999; Siatecka et al. 1999; Query
and Konarska 2004). Strikingly, P344 of Aar2p stacks
squarely on Y1858, and the following residues run like
a lid across C1878 (Figs.1C [panel II], 5A [inset]). These
two residues of RH could be UV-cross-linked in vitro to
a 39 single-stranded region of U4 snRNA and a 59 single-
stranded region of U6 snRNA, respectively (Mozaffari-
Jovin et al. 2012).
The above observations suggested that Aar2p might
interfere with RNA binding at the Prp8p RH domain. To
test this idea, we performed electrophoretic mobility
shift assays (EMSAs) with U4/U6 di-snRNA and either
CTF (containing RH linked to Jab1) or RH in the absence
and presence of Aar2p. Aar2p alone did not interact with
U4/U6 di-snRNA (Fig. 5B, lane 2), while CTF bound the
RNA complex efficiently (Fig. 5B, lane 3). CTF failed to
bindU4/U6when premixedwith an equimolar amount of
Aar2p (Fig. 5B, lane 4), and addition of increasing amounts
of Aar2p to a preformed CTF–U4/U6 complex led to pro-
gressive dissociation of the RNP (Fig. 5B, lanes 5–10).
Aar2p also counteracted U4/U6 binding to the RH domain
alone (Fig. 5C, lane 3). Surprisingly, the Aar2p C-terminal
extension that crosses the RH domain was not required for
this effect, as C-terminally truncated Aar2p1–331 also in-
terfered with U4/U6 binding by the RH domain (Fig. 5C,
lane 7). Therefore, either stable binding of U4/U6 di-
snRNA between the RH thumb and fingers requires sur-
faces on RH that are occluded by the globular part of Aar2p
or this part of Aar2p blocks the path of U4/U6 across the
RH domain (Fig. 5A). These data suggest that a second
function of Aar2p may be to preclude premature or non-
productive RNA binding to the Prp8p C-terminal region.
Structural and functional consequences
of phospho-mimetic mutations in Aar2p
Aar2p can be phosphorylated at five positions in vivo
(S253, T274, Y328, S331, and T345) (Supplemental Fig. S1),
and its reversible phosphorylation may regulate its ability
to competewith Brr2p (Weber et al. 2011). Consistent with
this idea, phospho-mimetic S253D or S253E mutations
interfered with Aar2p–Prp8p interaction in extracts (Weber
et al. 2011). S253 is located next to Aar2p helix a6
residuesM195, F198, and L199, which form a hydrophobic
pocket for W1911 of RH (Fig. 6A,B). To test whether this
RH-binding region of Aar2p could be structurally affected
by phosphorylation of S253, we produced and crystallized
the Aar21–318,Dloop,S253E protein. This variant contained a
C-terminal truncation to allow crystallization in the ab-
sence of Prp8p domains, the loop replacement also used
for crystallization of the Aar2pDloop–RH–Jab1 complex,
and the phospho-mimetic S253E exchange. The crystal
structure at 3.2 A˚ resolution contained two crystallo-
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graphically independent Aar2p1–318,Dloop,S253E molecules,
in both of which the helices a6/a7 region were dra-
matically reorganized (Fig. 6D–F). In the conformation
seen in Aar2pSubt (Fig. 6D) and the Aar2pDloop–RH–Jab1
complex (Fig. 6E), the larger E253 would clash with L205
in the N terminus of the a7–p1 helix. To accommodate
E253, helix a7–p1 is rotated upwards, the p1 part adopts
a-helical conformation, and residues L210 and F214 at
the center and C terminus of helix a7 interact with the
hydrophobic part of E253, whose carboxyl group is ex-
posed to the solvent (Fig. 6F). As a consequence, the
H193–R190–Y203 stacking interaction that anchors
the loop preceding helix a6 to the N terminus of helix
a7 is disrupted, and helix a6 unfolds completely. In
Aar2p1–318,Dloop,S253E, helix a6 residues M195, F198, and
L199,which formakey binding site for RH that is preformed
in Aar2pSubt, come to lie in a partially disordered loop. The
resulting conformation is sterically incompatible with bind-
ing to Prp8. We expect that a similar conformational change
will be observed upon phosphorylation of S253.
Below helix a7 in the Aar2p1–318,Dloop,S253E structure,
C251 from helix a9 and C292 from helix a12 reorganized
to form a disulfide bridge not seen in any previous
structure containing S253 Aar2p variants (Fig. 6F). We
believe that this disulfide has formed artificially upon
loss of reductive conditions during crystallization, show-
ing an increased flexibility in the region below helix a7
upon introducing the S253E exchange.
Notwithstanding these S253E-triggered conformational
changes, Brr2p competition was only partially relieved in
Figure 5. Aar2p interferes with U4/U6 di-snRNA binding to CTF. (A) Binding of the Aar2p C terminus (in sticks) along the thumb of
the RH domain (in surface representation). (Gold) Prp8p residues that, upon mutation, suppress defects in either splice site or the
branch point sequence of a pre-mRNA (Umen and Guthrie 1995, 1996; Collins and Guthrie 1999; Siatecka et al. 1999; Query and
Konarska 2004); (orange) Prp8-cat residues (Grainger and Beggs 2005), which, upon mutation, suppress u4-cs1 phenotypes (Kuhn et al.
1999; Kuhn and Brow 2000). The final 2Fo  Fc electron density contoured at the 1s level around the Aar2p C terminus is shown as
a blue mesh. Rotation symbols indicate the views relative to Figure 1B. (Inset) Position of Prp8p residues Y1858 and C1878 under the
Aar2p C terminus, which could be UV-cross-linked in vitro to U4 snRNA and U6 snRNA, respectively (Mozaffari-Jovin et al. 2012).
(B) EMSA monitoring binding of U4/U6 di-snRNA in the absence and presence of Aar2p. Protein names and concentrations are given at
the top of the gel. (Premix) Preincubation of the indicated components; (U6*) [32P]-labeled U6 snRNA. (C) EMSA monitoring the effects
of phospho-mimetic mutations (S253E, T345E, and S253E/T345E) and of a C-terminal deletion in Aar2p (Aar2p1–331) on its ability to
compete with U4/U6 di-snRNA for RH.
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Figure 6. Effect of phospho-mimetic mu-
tations in Aar2p on Brr2p–CTF complex
formation. (A) Position of two Aar2p phos-
phorylation sites, S253 and T345, in the
Aar2pDloop–RH–Jab1 complex structure.
Colors and labels are as in Figure 1C. (B)
Close-up view of Aar2p residue S253 (under-
lined) and its environment. (C) Close-up
view of Aar2p residue T345 (underlined)
and its environment. (D–F) Comparison of
the structures of Aar2pSubt (Weber et al.
2011), the Aar2pDloop–RH–Jab1 complex,
and Aar2p1–318,Dloop,S253E. (Blue mesh in F)
2Fo  Fc electron density covering the a7
region contoured at the 1s level. Rotation
symbols indicate the views relative to
Figure 1B. Insets show the a6/a7 region
in these structures, which is remodeled
upon introducing the S253E mutation. Ro-
tation symbols indicate the views relative
to the overviews. (G,H) Gel filtration
analysis probing the interaction of Aar2p
bearing phospho-mimetic mutations with
CTF and Brr2p. Details and labels are as in
Figure 2. Icons representing the proteins
are defined in the top right. All rotations
indicated are relative to Figure 1B. (G)
Aar2pT345E still binds CTF and excludes
Brr2p. (H) The Aar2pS253E/T345E variant
with two phospho-mimetic mutations no
longer interferes with Brr2p–CTF complex
formation.
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Aar2pS253E in vitro (Weber et al. 2011), suggesting that
Aar2pS253E can still be driven into a structure that re-
sembles wild-type Aar2p upon contacting Prp8. We there-
fore investigated whether additional phosphorylation
events may contribute to reducing Aar2p affinity for
CTF. T274 lies remote from the RH or Jab1 interfaces on
the opposite side of Aar2p and is unlikely to exert a direct
effect on CTF binding upon phosphorylation. Residues
Y328 and S331 map to the flexible peptide connecting the
bulk of Aar2p to its C terminus and were not visible in our
structure. However, T345 lies in a groove at the base of the
RH thumb and engages in water-mediated interactions
with RH residues T1855 and R1937 (Fig. 6A,C). Phosphor-
ylation might break this water network and sterically
interfere with the interaction. While a T345E version of
Aar2p still effectively competed with Brr2p for binding to
CTF (Fig. 6G), Brr2p was able to fully titrate CTF from the
Aar2pS253E/T345E double mutant (Fig. 6H).
ITC experiments (Supplemental Fig. 6E–H) corroborated
these findings. Affinities of Aar2pT345E and Aar2pS253E to
CTF were reduced about fivefold and 10-fold, respec-
tively, compared with wild-type Aar2p, while the double
Aar2pS253E/T345E mutant showed;170-fold weaker bind-
ing. Notably, thermodynamic parameters of these in-
teractions are in line with our structural findings. To bind
CTF, the disordered loop preceding helix a7 in isolated
Aar2pS253E is expected to contract and adopt a structure
similar to wild-type Aar2p. This scenario predicts an
enthalpic gain (due to the folding upon binding) and an
entropic loss (due to compaction and immobilization
of the unstructured region) compared with the wild type
as indeed seen in ITC (Supplemental Fig. 6E–G). More-
over, the clear effects seen in ITC with freshly pro-
duced, reduced Aar2pS253E protein argue that the disul-
fide bond seen in Aar2p1–318,Dloop,S253E can form as a
result of conformational changes due to the S253E muta-
tion rather than causing these conformational changes.
Together, these results suggest that phosphorylations at
S253 and T345 cooperatively reduce the ability of Aar2p
to bind Prp8.
We also tested whether the above phospho-mimetic
mutations in Aar2p affect its ability to interfere with the
Prp8p–U4/U6 interaction. Gel shift analyses indeed re-
vealed effects similar to those in the modulation of the
Prp8p–Brr2p interaction (Fig. 5C). Like C-terminally
truncated Aar2p1–331 (Fig. 5C, lane 7), Aar2pT345E still
counteracted RH–U4/U6 complex formation, whereas
both Aar2pS253E and the double mutant Aar2pS253E/T345E
were no longer able to compete with U4/U6 for RH
(Fig. 5C, lanes 4–6). These results suggest that in addition
to regulating Prp8p–Brr2p interactions, reversible phos-
phorylation of Aar2p can also control U4/U6 di-snRNA
binding at the Prp8p C-terminal region.
Mutations interfering with reversible phosphorylation
of Aar2p affect cell viability
To evaluate the cellular consequences of interfering with
reversible phosphorylation of Aar2p at specific sites, we
systematically replaced the endogenous copy of Aar2p
with variants bearing either a nonphosphorylatable ala-
nine or phospho-mimetic aspartic acid or glutamic acid
residues at positions 253, 274, 328, 331, or 345. Aar2p
variants S253A, S331A, and T274E, when present on the
genome, caused a cold-sensitive (cs) growth phenotype
(Supplemental Fig. S7A). While our structural and bio-
chemical findings do not provide an explanation for the
effects of the S331A and T274E mutations, the growth
defect in the case of Aar2pS253A may be explained by en-
hanced or prolonged binding of the mutant Aar2p to
Prp8p, blocking Brr2p binding or activation, or Prp8p
binding to U4/U6 di-snRNA, thus resulting in cs U4/U6
unwinding and reduced splicing. Moreover, using the
same approach, viable yeast cells bearing double S253A/
T345A or S253E/T345Emutations could not be recovered
at 30°C, indicating that concomitant phospho-mimetic or
nonphosphorylatable mutations at these two residues are
synthetic-lethal. This observation is in line with our find-
ing that phospho-mimetic residues at these sites coopera-
tively weaken the Aar2p–Prp8 interaction in vitro.
We also investigated the effect of Aar2p phospho-
mimetic mutations on the growth inhibition caused by
co-overproducing Aar2p and Prp8p CTFs (Supplemental
Fig. S7B). Prp8 fragment E1 (residues 1649–2413) starts
N-terminal of the RH domain and extends to the end of
Prp8p. Fragment E3 (residues 2010–2413) includes the
C-terminal part of the RH domain and the Jab1 domain.
Fragment E3H corresponds to E3 with two point muta-
tions (Y2037H and I2051T) that increase the interaction
of the fragment with Brr2p (van Nues and Beggs 2001).
The results (Supplemental Fig. S7B) are summarized in
Supplemental Table S3. Co-overproduction with E1 had
few discernible effects. However, as we reported previ-
ously (Weber et al. 2011), overproduction of E3 and, more
so, E3H in the presence of Aar2p is detrimental for growth
but is counteracted by the S253E mutation.
We now see that substitutions of T274 and T345 in
Aar2p have differential effects with E3 and E3H, which
are similar for both alanine and aspartate/glutamate sub-
stitutions. The E3 and E3H fragments lack most of the
RH domain, including portions that build up contact
regions I, II, and III with Aar2p in the Aar2pDloop–RH–Jab1
complex (Fig. 1B). Thus, Aar2p or variants and E3 or E3H
fragments should act physically independently of each
other. Based on our findings, Aar2p competes with Brr2p
for Prp8p. E3 and E3H are expected to disturb this equi-
librium by binding Brr2p in competition with endogenous
Prp8p. Since E3H has a higher affinity for Brr2p, it is
expected to compete more efficiently, consistent with
its higher toxicity. Based on our in vitro structural and
binding studies, Aar2pT345E exhibits a weaker affinity
for Prp8p than wild-type Aar2p. When overproduced,
Aar2pT345E will, to some extent, compete with endoge-
nous wild-type Aar2p for Prp8p and provide a Prp8p pool
associated with a more easily detached Aar2p variant. In
this fashion, Aar2pT345E overproduction could make up
for the reduced Prp8p-binding capacity of Brr2p in the
presence of E3 or E3H. Again, we cannot explain the
T274 effects based on our structural and biochemical
findings. Taken together, the growth phenotypes observed
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upon replacing wild-type Aar2p with phospho-mutants
and upon co-overproducing Aar2p phospho-mutants and
Prp8p CTF could be explained by the weakening of Aar2p–
Prp8p interaction upon phosphorylation of Aar2p residues
S253 and T345.
Discussion
Apart from the PRMT5 and SMN complexes that guide
the formation of the Sm core RNPs, only a small number
of factors have been characterized that are intermediate
subunits of snRNPs but are not integrated into higher-
order snRNP assemblies or the spliceosome, representing
bona fide assembly factors or chaperones. Perhaps the
most prominent example is the Prp24 protein (human
p110), which is a subunit of U6 snRNP but is not found in
U4/U6 di-snRNP and which facilitates the annealing of
U4 and U6 snRNAs during U4/U6 di-snRNP formation
(Raghunathan and Guthrie 1998b; Bell et al. 2002). In
addition, Lin1p (human U5-52K protein) is specifically as-
sociated with U5 snRNP but is released upon U4/U6-U5
tri-snRNP formation (Laggerbauer et al. 2005). The
specific function of this protein is presently unknown.
Furthermore, several proteins that are associated with
spliceosomes have been attributed an additional snRNP
assembly function. Both the Lsm2–8 protein complex of
U6 snRNP (Rader and Guthrie 2002; Ryan et al. 2002;
Verdone et al. 2004) and the Prp19 complex (Chen et al.
2006) were implicated in U4/U6 di-snRNP biogenesis.
The Aar2p protein represents the most recent addition to
this group of putative or proven snRNP assembly chaper-
ones. Aar2p was the first example of a factor that regulates
the incorporation of a snRNP-specific protein, Brr2p. As
shown here, it can additionally regulate U4/U6 di-snRNA
binding to Prp8p. We employed a combined structural and
biochemical approach to investigate the molecular mech-
anisms underlying these possibly functionally related ac-
tivities of Aar2p in detail (Fig. 7).
Aar2p cements an autoinhibited structure
in the C-terminal region of Prp8p
Brr2p has been shown to directly bind the Jab1 domain
of Prp8p (Weber et al. 2011). Notably, the unstructured
Figure 7. Scheme illustrating the functions of Aar2p during U5 snRNP assembly. In pre-U5 snRNP, Aar2p blocks RNA (e.g., U4/U6)
and Brr2p binding to the Prp8p C-terminal region. Phosphorylation of Aar2p at S253 and T345 in the nucleus (by unknown kinases)
leads to its detachment from Prp8p and allows Brr2p binding to form mature U5 snRNP. The same signals allow the RH domain of
Prp8p to bind U4/U6 di-snRNA and inhibit their premature unwinding by Brr2p in the U4/U6-U5 tri-snRNP. The precise sequence of
phosphorylation events is presently unknown. To participate in further rounds of U5 snRNP assembly, Aar2p has to be dephos-
phorylated by an unknown phosphatase and shuttled back to the cytoplasm. (NPC) Nuclear pore complex.
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C-terminal tail of the Jab1 domain, which is crucial for
Brr2p binding (Boon et al. 2007; Pena et al. 2007; Maeder
et al. 2009), is not involved in contacts to Aar2p or RH in
our present complex structure. Nevertheless, Aar2p effi-
ciently competes with Brr2p binding to Prp8p CTF (Fig.
4B). While Aar2p or RH could occupy additional essential
Brr2p interaction regions on Jab1, we favor the idea that
they are attached to Jab1 in a manner that sterically in-
terferes with Brr2p binding. This latter interpretation
would provide a straightforward explanation for the en-
hanced binding of the E3H fragment to Brr2p compared
with E3 (van Nues and Beggs 2001). One of the residues
mutated in E3H, I2051, stabilizes contact region VI of
the present Aar2pDloop–RH–Jab1 complex (Fig. 1C, panel VI)
between the RH and Jab1 domains. Assuming that the RH
portion in E3H sterically hinders Brr2p from interacting
with Jab1, weakening of the RH–Jab1 interaction should
alleviate this inhibition. Attractively, this explanation
for the gain-of-function phenotype of E3H does not invoke
an unlikely improvement of direct interactions between
the mutated residues in E3H and Brr2p.
As essentially the same Jab1 surfaces are covered by
RH alone in the structure of the isolated CTF as by RH
together with the slender Aar2p C-terminal b strand
in the Aar2pDloop–RH–Jab1 complex (Supplemental Fig.
S3C,D), we expect that CTF in its observed closed con-
formation would also be unable to bind Brr2p and would
have to undergo a conformational change to interact
with the helicase. As Brr2p efficiently binds CTF in the
absence of Aar2p in vitro (Fig. 4A), it can break open the
presumed autoinhibitory conformation of CTF. Aar2p
reinforces the inhibitory RH–Jab1 interaction and may
render this part of Prp8p more rigid so that conforma-
tional changes required for Brr2 binding can no longer
occur. CTF resembles many other regulatory proteins,
which contain multiple domains that interact with dif-
ferent binding partners (Pawson and Nash 2003). Auto-
inhibition via intramolecular domain–domain interac-
tions is a widespread regulatory principle in such factors
(Pufall and Graves 2002; Mackereth et al. 2011; Burmann
et al. 2012). In the present case, Aar2p adds an additional
level of regulation, representing an assembly factor that
counteracts Brr2p binding to Prp8p by reinforcing an
autoinhibited conformation in Prp8p CTF.
Aar2p coordinates the binding of Brr2p and U4/U6
di-snRNA to the Prp8p C-terminal region
Our results show that apart from competing with Brr2p
for binding to Prp8p, Aar2p also interferes with binding
of U4/U6 di-snRNA to Prp8p CTF (Fig. 5B,C). The latter
observation may simply indicate an additional role of
Aar2p in safeguarding against premature or nonspecific
RNA interactions at the Prp8p C-terminal region during
U5 snRNP assembly. However, the two seemingly dis-
parate activities of Aar2p may also be functionally
closely interrelated. During spliceosome catalytic acti-
vation, Brr2p unwinds the U4/U6 duplex and displaces
all U4/U6-associated proteins (Laggerbauer et al. 1998;
Raghunathan and Guthrie 1998a). This activity of Brr2p
needs to be tightly controlled because the enzyme al-
ready encounters its U4/U6 substrate in the U4/U6–U5
tri-snRNP before incorporation into the spliceosome.
We recently found that the Prp8p RH domain acts as an
inhibitor of Brr2p by occluding regions of U4/U6 di-
snRNA also required for Brr2p binding (Mozaffari-Jovin
et al. 2012). Our present competition assays (Fig. 5B,C)
show that the RH domain is released from Aar2p by the
same signals that make the Jab1 available to Brr2p. Thus,
with the entry of Brr2p into U5 snRNP, the Prp8p RH
domain is ready to dock the U4/U6 di-snRNA (Fig. 7). This
assembly strategy would thus be suitable to ensure that
mature U5 snRNP is incorporated into U4/U6–U5 tri-
snRNP in a way that precludes premature unwinding of
U4/U6.
It is possible that the subnuclear sites of tri-snRNP
assembly coincide with the locations where U5 snRNP is
matured; e.g., the Cajal bodies in higher eukaryotes.
On the other hand, a free pool of mature U5 snRNP
exists in yeast (Stevens et al. 2001) and other eukary-
otes (Bringmann and Lu¨hrmann 1986). Therefore, fur-
ther work is required to determine whether Aar2p only
functions as a U5 snRNP assembly factor or additionally
coordinates or physically links U5 snRNP and U4/U6-U5
tri-snRNP assembly.
Strategy for Aar2p release
During the assembly of macromolecular machines, as-
sembly factors may engage in interactions that have to be
released again during later stages of assembly or have to
unleash biological activity (Chari and Fischer 2010).
Obviously, the affinities of such factors for their assembly
intermediates have to be finely tuned to avoid terminal
stalling of the assembly process. In the case of Aar2p, the
sizeable Aar2p–CTF interaction surface (2125 A˚2 of buried
surface area) is distributed among several smaller inter-
faces (Fig. 1C, panels I–VI). Each of these interfaces alone is
easier to disrupt than a continuous protein–protein in-
teraction surface of the combined size (Fig. 7). A similar
strategy has been suggested for the s factor that guides
bacterial RNA polymerase to its promoters but has to be
released upon entry of the elongation phase (Murakami
and Darst 2003).
Our observations with phospho-mimetic mutations
suggest that the affinity of Aar2p for CTF is regulated by
reversible phosphorylation (Weber et al. 2011). We identi-
fied two putative regulatory residues: S253 and T345.
Phospho-mimetic mutations at these residues coopera-
tively reduced Aar2p interaction with Prp8p CTF (Fig. 6;
Supplemental Fig. S6E–H), and double nonphosphory-
latable S253A/T345A or phospho-mimetic S253E/T345E
mutations were synthetic-lethal. These observations sug-
gest that phosphorylation of S253 and T345 of Aar2p affect
the same process; i.e., release of Aar2p from Prp8p during
U5 snRNP assembly. The distribution of the two residues
among the Aar2p–Prp8p interfaces suggests that down-
regulation of Aar2p affinity by phosphorylation is effi-
ciently combined with facilitation of Aar2p release based
on multiple small contact surfaces—phosphorylation of
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S253 interferes with the contact region I, and phosphor-
ylation of T345 interferes with contact region II (Figs. 1C, 7).
The above principles are corroborated by our observa-
tion that the interaction of the Aar2p C-terminal expan-
sion alone with CTF is very weak (Fig. 1E). Although this
interaction is highly specific due to the large buried sur-
face area (1195 A˚2), the intrinsically unstructured nature of
the Aar2p C-terminal expansion (and the concomitant
loss in entropy associated with its immobilization) ren-
ders the interaction onlymarginally stable and dependent
on the anchoring of the globular part of Aar2p on RH (Fig.
1D,E) and allows it to be easily undone; e.g., via a phos-
phorylation event. Thus, Aar2p combines several strate-
gies (dissection of the total interaction surface, multiple
phosphorylation events that affect different interfaces,
and entropy-enthalpy compensation) to act as a revers-
ible inhibitor of macromolecular interactions during
U5 snRNP assembly.
Possible roles of Aar2p in spliceosome disassembly
and U5 snRNP recycling
During the splicing process, several snRNPs are pro-
foundly remodeled (Staley and Guthrie 1998; Wahl et al.
2009). Thus, for continued pre-mRNA splicing, the
snRNPs have to be regenerated after each round of splic-
ing. Interestingly, it has been observed that Aar2p-depleted
nuclear extract did not permit consecutive rounds of
splicing (Gottschalk et al. 2001). Thus, Aar2p not only
may be involved in the de novo biogenesis of U5 snRNP,
but could also play a role in spliceosome disassembly
and/or U5 snRNP recycling.
Spliceosome disassembly is the least understood phase
of the splicing reaction. While proteomics analyses of
purified spliceosomal complexes have not detected Aar2p
in spliceosome assembly or catalysis intermediates, the
complete proteome of post-splicing complexes is presently
unknown. The Prp8p RH domain is thought to act as an
assembly platform for the catalytic RNA network of the
spliceosome (Pena et al. 2008; Ritchie et al. 2008; Yang
et al. 2008). However, UV cross-links between components
of this network and other regions of Prp8p during later
stages of the splicing reaction (Turner et al. 2006) suggest
that catalytic core RNAs are handed over to other binding
sites after initial assembly on the RHdomain. Thus, late in
the splicing cycle, the Prp8p RH domain may be available
for rebinding of Aar2p. Whether rebinding of Aar2p at RH
actually occurs, whether it would also affect Prp8p–Brr2p
interactions during spliceosome disassembly, and whether
U5 snRNP recycling resembles its de novo biogenesis
pathway remain to be investigated.
Materials and methods
Protein production and crystallographic analyses
All yeast proteins for biochemical, biophysical, and structural
studies, except Brr2p, were produced in E. coli and purified to
near homogeneity by chromatographic techniques. Brr2p was
produced in insect cell culture (Santos et al. 2012). Crystallization
was performed by the sitting drop vapor diffusion method, and
diffraction data were collected on beamline 14.2 of the BESSY II
storage ring. The structures were solved by molecular replace-
ment and refined with standard protocols. Details for these and
other methods are given in the Supplemental Material.
ITC and EMSA
ITC measurements were conducted on a MicroCal iTC200
system (GE Healthcare) using Jab1 and Jab1linker as a sample
and Aar2p–RH complex as the titrant. U4 and U6 snRNAs were
in vitro transcribed by T7 polymerase. The U6 snRNA was 59-
end-radiolabeled and annealed to the U4 snRNA, followed by
purification of the U4/U6 di-snRNA by 6% nondenaturing
PAGE. Complex formation was analyzed on a native polyacryl-
amide gel and visualized by autoradiography.
Database deposition
Structure coordinates and diffraction data were deposited
with the Protein Data Bank (http://www.pdb.org) under acces-
sion codes 4ILG (Aar2pDloop-RH-Jab1), 4ILJ (RHW1911A), 4ILH
(Aar2p1–331-RH), and 4ILI (Aar2p1–318,Dloop,S253E) and will be
released upon publication.
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